Authors: AJAYIOBE EK LODI E ALKALI AS GALBATI M ROONEY C MANNONI B GRIM P NASIDI A MOHAMMED I

Citation: Ek. Ajayiobe et al., PROGNOSTIC SCORES FOR USE IN AFRICAN MENINGOCOCCAL EPIDEMICS, Bulletin of the World Health Organization, 76(2), 1998, pp. 149-152

Authors: MEYER WP HABIB AG ONAYADE AA YAKUBU A SMITH DC NASIDI A DAUDU IJ WARRELL DA THEAKSTON RDG

Citation: Wp. Meyer et al., FIRST CLINICAL-EXPERIENCES WITH A NEW OVINE FAB ECHIS-OCELLATUS SNAKEBITE ANTIVENOM IN NIGERIA - RANDOMIZED COMPARATIVE TRIAL WITH INSTITUTE-PASTEUR SERUM (IPSER) AFRICA ANTIVENOM, The American journal of tropical medicine and hygiene, 56(3), 1997, pp. 291-300

Authors: FISHERHOCH SP TOMORI O NASIDI A PEREZORONOZ GI FAKILE Y HUTWAGNER L MCCORMICK JB

Citation: Sp. Fisherhoch et al., REVIEW OF CASES OF NOSOCOMIAL LASSA FEVER IN NIGERIA - THE HIGH PRICEOF POOR MEDICAL-PRACTICE, BMJ. British medical journal, 311(7009), 1995, pp. 857-859

Authors: IDIGBE EO NASIDI A ANYIWO CE ONUBOGU C ALABI S OKOYE R UGWU O JOHN EKO

Citation: Eo. Idigbe et al., PREVALENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ANTIBODIES IN TUBERCULOSIS PATIENTS IN LAGOS, NIGERIA, Journal of tropical medicine and hygiene, 97(2), 1994, pp. 91-97

Authors: DADA AJ OYEWOLE F ONOFOWOKAN R NASIDI A HARRIS B LEVIN A DIAMONDSTONE L QUINN TC BLATTNER WA

Citation: Aj. Dada et al., DEMOGRAPHIC CHARACTERISTICS OF RETROVIRAL INFECTIONS (HIV-1, HIV-2, AND HTLV-I) AMONG FEMALE PROFESSIONAL SEX WORKERS IN LAGOS, NIGERIA, Journal of acquired immune deficiency syndromes, 6(12), 1993, pp. 1358-1363

Authors: NASIDI A MONATH TP VANDENBERG J TOMORI O CALISHER CH HURTGEN X MUNUBE GRR SORUNGBE AOO OKAFOR GC WALI S

Citation: A. Nasidi et al., YELLOW-FEVER VACCINATION AND PREGNANCY - A 4-YEAR PROSPECTIVE-STUDY, Transactions of the Royal Society of Tropical Medicine and Hygiene, 87(3), 1993, pp. 337-339